Prelude Therapeutics Inc (PRLD) Company Profile & Statistics

Prelude Therapeutics Inc
PRLD
(Nasdaq - US)
N/A
3.87
+0.01 (+0.26%)
in:usd•As of: May 06, 2024 15:59 UTC -4
Open
3.89
High
3.99
Low
3.86

About Prelude Therapeutics Inc

CEO

Krishna Vaddi

Headquarters

175 innovation boulevard

wilmington, de 19805, united states

Auditor

Ernst & Young LLP

Employees

128

Share Holders

Website

www.preludetx.com

Industry

biotechnology

Sector

health technology

Company Overview

Prelude Therapeutics Incorporated is a clinical-stage precision oncology company. It is focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. Prelude Therapeutics Incorporated is based in Wilmington, United States.

Prelude Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	162.85M
Enterprise Value	137.56M
Enterprise Value/EBITDA (ttm)	-1.02
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.89
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-53.39%
Return on Invested Capital (ttm)	-54.22%
Return on Assets (ttm)	-48.01%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-134.58M
Net Income Avi to Common (ttm)	-121.83M
Diluted EPS (ttm)	-2.04

Share Statistics

Beta (5Y Monthly)	1.56
52-Week Change	-39.25%
S&P500 52-Week Change	27.73%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	54.92M
Dividend Yield	0.00%
Float ⁴	8.61M
% Held by Insiders	79.54%
% Held by Institutions	79.72%

Balance Sheet

Total Cash (mrq)	232.94M
Total Cash Per Share (mrq)	4.24
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	10.79%
Quick Ratio (mrq)	10.79%
Book Value Per Share (mrq)	4.32

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.77
Free Cash Flow (ytd)	-110.58M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Prelude Therapeutics Inc

Trade With A Regulated Broker